Trial NCT00960804

View at ClinicalTrials.gov 
Org. Study IDs: A4091040
Secondary IDs: NERVE FUNCTION EXTENSION STUDY

Last trial update was posted on 2021-02-08

MeSH Interventions

Tanezumab

MeSH Conditions

Osteoarthritis

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to FDA-imposed clinical hold, enrollment stopped prematurely, thus inadequate power to fulfill primary objectives.Efficacy data beyond Week 32 not collected.Change in planned analysis added results of >=70%, 90% reduction in WOMAC pain subscale.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID